Frontiers in Anti-infective Drug Discovery, Volume (1)

eBooks End User License Agreement......Page 2
Volume 1 Contents......Page 3
PREFACE......Page 5
Strategies for Effective Naked-DNA Vaccination Against Infectious Diseases......Page 11
Light Activated Compounds as Patented Antimicrobial Agents......Page 27
Proteases and Kinases: Attractive Targets for Combating Infectious Diseases......Page 59
Antibacterial Therapy in the Elderly......Page 80
SARS Coronavirus Anti-Infectives......Page 93
Probiotics as Drugs Against Human Gastrointestinal Pathogens......Page 117
Insights into the Treatment of Helicobacter pylori Infection......Page 134
Inhibitors of Bacterial Efflux Pumps as Adjuvants in Antibacterial Therapy and Diagnostic Tools for Detection of Resistance by Efflux......Page 148
Drugs Candidates in Advanced Clinical Trials Against Tuberculosis......Page 186
Drug Effects on Drug Targets: Inhibition of Enzymes by Neuroleptics, Antimycotics, Antibiotics and Other Drugs on Human Pathogenic Amoebas and their Anti-Proliferative Effects......Page 212
Macrophage Inflammatory Protein 1 and CCR5 as Potential Therapeutic Targets for HIV Infection and Acquired Immunodeficiency Syndrome......Page 237
Small-Molecule Inhibitors of Raf for Treatment of Malignant Diseases......Page 248
Tigecycline: A New Treatment Choice Against Acinetobacter baumannii......Page 261
Cefepime and its Role in Pediatric Infections......Page 271
Antibacterial Properties of Organosulfur Anti-Infectives: A Review of Patent Literature 1999-2009......Page 279
A Review of the Carbapenems in Clinical Use and Clinical Trials......Page 289
Anti-Infective Quinone Derivatives of Recent Patents......Page 304
Targets and Patented Drugs for Chemotherapy of Chagas Disease......Page 333
Recent Patents on Development of Nucleic Acid-Based Antiviral Drugs against Seasonal and Pandemic Influenza Virus Infections......Page 419
Author Index to Volume 1......Page 436